FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 297:303-307 August 11, 1977 Number 6 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To elucidate the hemodynamic effects of prazosin, an antihypertensive agent, in congestive heart failure, we studied 10 patients with ischemic cardiomyopathy and severe ventricular dysfunction. After an oral dose of 2 to 7 mg, heart rate was unchanged (P greater than 0.05). One hour after prazosin administration, mean arterial pressure declined from 95 to 78 mm Hg (P less than 0.001); left ventricular filling pressure declined from 30 to 18 mm Hg (P less than 0.001), cardiac index increased from 2.1 to 2.9 liters per minutes per square meter (P less than 0.001), and systemic vascular resistance fell from 2074 to 1156 dynes sec cm-5 (P less than 0.001). In both forearms vascular resistance and venous tone were reduced (86 to 48 mm Hg per ml per 100 g per minute, and 59 to 18 mm Hg per ml, respectively [P less than 0.001]). All responses persisted for a least six hours (P less than 0.01). Prazosin benefits severe congestive heart failure by inducing a sustained fall of both cardiac preload and impedance.

This article has been cited by other articles:

• Groden, D. L. (1993). Vasodilator Therapy for Congestive Heart Failure: Lessons From Mortality Trials. Arch Intern Med 153: 445-454 [Abstract]  
• FRANCIS, G. S., GOLDSMITH, S. R., LEVINE, T. B., OLIVARI, M. T., COHN, J. N. (1984). The Neurohumoral Axis in Congestive Heart Failure. ANN INTERN MED 101: 370-377 [Abstract]  
• GREENBERG, B. H., SCHUTZ, R., GRUNKEMEIER, G. L., GRISWOLD, H. (1982). Acute Effects of Alcohol in Patients with Congestive Heart Failure. ANN INTERN MED 97: 171-175 [Abstract]  
• COLUCCI, W. S. (1982). Alpha-Adrenergic Receptor Blockade with Prazosin: Consideration of Hypertension, Heart Failure, and Potential New Applications. ANN INTERN MED 97: 67-77 [Abstract]  
• MAGORIEN, R. D., TRIFFON, D. W., DESCH, C. E., BAY, W. H., UNVERFERTH, D. V., LEIER, C. V. (1981). Prazosin and Hydralazine in Congestive Heart Failure: Regional Hemodynamic Effects in Relation to Dose. ANN INTERN MED 95: 5-13 [Abstract]  
• Cobaugh, D. S. (1980). Prazosin Treatment of Ergotamine-Induced Peripheral Ischemia. JAMA 244: 1360-1360 [Abstract]  
• COHN, J. N., BURKE, L. P. (1979). Nitroprusside. ANN INTERN MED 91: 752-757 [Abstract]  
• ARNOLD, S. B., WILLIAMS, R. L., PORTS, T. A., BAUGHMAN, R. A., BENET, L. Z., PARMLEY, W. W., CHATTERJEE, K. (1979). Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart Failure. ANN INTERN MED 91: 345-349 [Abstract]  
• Hutchinson, R. G. (1979). Medical Management of Hypertension. ANGIOLOGY 30: 558-567  
• Reyns, P., Romney, D., Desser, K. B., Benchimol, A. (1979). Serial Hemodynamic Studies During the Treatment of Congestive Heart Failure With Isolated Low-Dose Oral Prazosin Therapy. ANGIOLOGY 30: 850-855 [Abstract]  
• Pierpont, G. L., Cohn, J. N., Franciosa, J. A. (1978). Congestive Cardiomyopathy: Pathophysiology and Response to Therapy. Arch Intern Med 138: 1847-1850 [Abstract]  
• Laslett, L. J., DeMaria, A. N., Amsterdam, E. A., Mason, D. T. (1978). Hydralazine-Induced Tachycardia and Sodium Retention in Heart Failure: Hemodynamic and Symptomatic Correction by Prazosin Therapy. Arch Intern Med 138: 819-820 [Abstract]